semaglutide and restless leg syndrome Syndrome, Illustration | Stock Image Restless legs syndrome (RLS) is

Compounded GLP-1s are a glucagon-like peptide-1 (GLP-1) receptor agonist which may be used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

Embarking on a weight loss journey can feel overwhelming

This microglial shift represents one of the most therapeutically relevant mechanisms in cerebrolysin research

Studies show that rapid weight loss without targeted supplementation can deplete B vitamins, iron, and vitamin D